BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 30864272)

  • 41. Increased risk of PTLD in lung transplant recipients with cystic fibrosis.
    Lowery EM; Adams W; Grim SA; Clark NM; Edwards L; Layden JE
    J Cyst Fibros; 2017 Nov; 16(6):727-734. PubMed ID: 28456611
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Surveillance of Epstein-Barr virus infection as a risk factor for post-transplant lymphoproliferative disorder in pediatric renal transplant recipients.
    Köpf S; Tönshoff B
    Pediatr Nephrol; 2004 Apr; 19(4):365-8. PubMed ID: 14963763
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Posttransplant Epstein-Barr virus-associated myogenic tumors: case report and review of the literature.
    Sprangers B; Smets S; Sagaert X; Wozniak A; Wollants E; Van Ranst M; Debiec-Rychter M; Sciot R; Vanrenterghem Y; Kuypers DR
    Am J Transplant; 2008 Jan; 8(1):253-8. PubMed ID: 18184312
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epstein-Barr virus-associated smooth muscle tumor presenting as a vulvar mass in an acquired immunodeficiency syndrome patient: a case report.
    Khunamornpong S; Sukpan K; Suprasert P; Shuangshoti S; Pintong J; Siriaunkgul S
    Int J Gynecol Cancer; 2007; 17(6):1333-7. PubMed ID: 17511803
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epstein-Barr virus-associated smooth muscle tumors in immunocompromised patients: Six case reports.
    Khan AA; Estfan BN; Yalamanchali A; Niang D; Savage EC; Fulmer CG; Gosnell HL; Modaresi Esfeh J
    World J Clin Oncol; 2022 Jun; 13(6):540-552. PubMed ID: 35949429
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rare Presentations of Epstein-Barr Virus--Associated Smooth Muscle Tumor in Children.
    Arva NC; Schafernak KT
    Pediatr Dev Pathol; 2016; 19(2):132-8. PubMed ID: 26230054
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Latent Epstein-Barr virus infection demonstrated in low-grade leiomyosarcomas of adults with acquired immunodeficiency syndrome, but not in adjacent Kaposi's lesion or smooth muscle tumors in immunocompetent patients.
    Boman F; Gultekin H; Dickman PS
    Arch Pathol Lab Med; 1997 Aug; 121(8):834-8. PubMed ID: 9278611
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A population-based study of 135 lymphomas after solid organ transplantation: The role of Epstein-Barr virus, hepatitis C and diffuse large B-cell lymphoma subtype in clinical presentation and survival.
    Kinch A; Baecklund E; Backlin C; Ekman T; Molin D; Tufveson G; Fernberg P; Sundström C; Pauksens K; Enblad G
    Acta Oncol; 2014 May; 53(5):669-79. PubMed ID: 24164103
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Viral load of EBV DNAemia is a predictor of EBV-related post-transplant lymphoproliferative disorders in pediatric renal transplant recipients.
    Colombini E; Guzzo I; Morolli F; Longo G; Russo C; Lombardi A; Merli P; Barzon L; Murer L; Piga S; Ciofi Degli Atti ML; Locatelli F; Dello Strologo L
    Pediatr Nephrol; 2017 Aug; 32(8):1433-1442. PubMed ID: 28280938
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Kidney Graft Leiomyosarcoma: A Case Report.
    Laranjinha I; Matias P; Jorge C; Birne R; Weigert A; Adragão T; Bruges M; Cabrera RA; Cassis J; Ramos S; Nogueira A; Godinho J; Messias H; Machado D
    Transplant Proc; 2016 Sep; 48(7):2379-2383. PubMed ID: 27742302
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical and virologic outcomes in high-risk adult Epstein-Barr virus mismatched organ transplant recipients.
    Kumar D; Patil N; Husain S; Chaparro C; Bhat M; Kim SJ; Humar A
    Clin Transplant; 2017 Jul; 31(7):. PubMed ID: 28489256
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Diffuse lymphoproliferative disease after renal transplantation and its relation with Epstein-Barr virus. Experience at one center].
    Franco A; Jiménez L; Aranda I; Alvarez L; González M; Rocamora N; Olivares J
    Nefrologia; 2002; 22(5):463-9. PubMed ID: 12497748
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Evaluation of PCR results in the diagnosis of Epstein-Barr virus infections].
    Karadağ Geçgel S; Ersoy A; Sevinir BB; Sınırtaş M; Göral G
    Mikrobiyol Bul; 2012 Oct; 46(4):594-606. PubMed ID: 23188573
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tumor origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients: implications for immune-based therapy.
    Gulley ML; Swinnen LJ; Plaisance KT; Schnell C; Grogan TM; Schneider BG;
    Transplantation; 2003 Sep; 76(6):959-64. PubMed ID: 14508361
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acute cellular rejection and Epstein-Barr virus-related post-transplant lymphoproliferative disorder in a pediatric lung transplant with low viral load.
    Calabrese F; Loy M; Lunardi F; Marino D; Aversa SM; Rea F
    Transpl Infect Dis; 2010 Aug; 12(4):342-6. PubMed ID: 20030794
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transplantation of solid organ recipients shedding Epstein-Barr virus DNA pre-transplant: A prospective study.
    Verghese PS; Schmeling DO; Filtz EA; Grimm JM; Matas AJ; Balfour HH
    Clin Transplant; 2017 Nov; 31(11):. PubMed ID: 28915342
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term follow-up of post renal transplantation Epstein-Barr virus-associated smooth muscle tumors: Report of two cases and review of the literature.
    El Hennawy HM; Habhab W; Almutawa A; Shinawi S; Al Ayad A; Fahmy A
    Transpl Infect Dis; 2018 Apr; 20(2):e12841. PubMed ID: 29359839
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epstein-Barr virus associated smooth muscle tumors in post transplant pediatric patients two cases of rare locations, and review of the literature.
    Elawabdeh N; Cone BM; Abramowsky CR; Wrubel DM; Grossniklaus H; Walrath J; Bashir MZ; Shehata BM
    Fetal Pediatr Pathol; 2013 Jun; 32(3):184-91. PubMed ID: 23445451
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Posttransplant lymphoproliferative disorders in lung transplant recipients: clinical experience at a single center.
    Angel LF; Cai TH; Sako EY; Levine SM
    Ann Transplant; 2000; 5(3):26-30. PubMed ID: 11147026
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression of EBV latent antigens, mammalian target of rapamycin, and tumor suppression genes in EBV-positive smooth muscle tumors: clinical and therapeutic implications.
    Ong KW; Teo M; Lee V; Ong D; Lee A; Tan CS; Vathsala A; Toh HC
    Clin Cancer Res; 2009 Sep; 15(17):5350-8. PubMed ID: 19706821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.